To compare efficacy of treatment by intralesional bleomycin and intralesional vitamin D-3 in common warts.
Not Applicable
Completed
- Conditions
- Health Condition 1: B078- Other viral warts
- Registration Number
- CTRI/2021/04/032610
- Lead Sponsor
- Department of Dermatology Venereology and Leprosy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
1. All untreated consecutive patients having single/ multiple lesions of verruca vulgaris.
2. Patients above the age of 14 years.
Exclusion Criteria
1. Pregnant or lactating females.
2. Immunocompromised individuals including HIV.
3. Patients known to have hypersensitivity to vitamin D-3.
4. Patients having history of peripheral vascular disorders like scleroderma or Raynaudââ?¬•s phenomenon.
5. Patients with pulmonary fibrosis.
6. History of intake of vitamin D-3, anabolic steroids, bisphosphonates in the last 3 months or history of intravenous chemotherapy with bleomycin in the past.
7. Patients having any significant systemic illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the therapeutic efficacy of intralesional bleomycin and intralesional vitamin D-3 in verruca vulgaris.Timepoint: A total of three sessions at an interval of two weeks shall be instituted in both groups (i.e. 0, 2 and 4 weeks). Patients will be followed at 8th week.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI